Binary alloys of chromium-iron (Cr-Fe) are no longer used in dental and orthopaedic applications, and were used only for comparative purposes in the present study. Four kinds of Cr-Fe binary alloys, namely, 10 mass%, 15 mass%, 20 mass% and 30 mass%Cr in Fe, and 100%Cr and SUS316L were prepared. These metals were subcutaneously implanted into rats for four months. There was no significant difference in body weights and organ weights among control (sham-operation) and implant-groups, and no significant accumulation of Cr and Fe in the blood, liver or kidney of the alloy implant groups. To clarify the usefulness of urinary monitoring, the Cr and Fe concentrations in rat urine after implantation were analyzed. Alloy implant groups, including the SUS316L group, intended to excrete higher urinary Cr amounts than the control group during the 3 weeks after implantation. Urinary Cr and Fe amounts of the 15%Cr-alloy group showed especially high values in comparison not only with the control level but also the other alloy groups. The visual corrosion extents of the retrieved implants showed the following order: 10%Cr > 15%Cr > 20%Cr > 30%Cr > 100%Cr, SUS316L, and did not always correlate with the levels of the urinary amounts of Cr and Fe. From these findings, monitoring of urinary metal amounts is considered to be useful to monitor the in vivo elution property non-invasively.
Introduction
Nickel and chromium are two metals that have been recognized to be carcinogenic in man and animals, and have also been shown to be essential for animal nutrition. 1) If human exposure to nickel and chromium were eliminated, deleterious nutritional deficiencies would probably ensue. In light of these scientific developments, the "no-threshold" concept of chemical carcinogenesis could not justifiably be applied to nickel and chromium. Therefore the balancec risk of carcinogenicity and nutritional deficiency should be considered in the formulation of governmental regulations regarding human exposures to these metals. 1) Chromium (Cr) is known as not only a human carcinogen 1) but also a strong sensitizer.
2) Carcinogenesis bioassays have shown that some Cr compounds induce malignant neoplasms following administration in experimental animals by inhalation or parenteral routes. 3, 4) Several studies have surveyed case reports of local neoplasms in patients with metal orthopedics, and have suggested that metal particles produced by mechanical wear or metal ions release by corrosion might be initiating such malignancies. 5) Orthopedic surgeons and prosthesis manufactures are concerned about excess corrosion of metallic materials.
6) The principal mechanisms by which surgical alloys corrode are galvanic, crevice and fitting corrosions. These types of degradation involve the release of ions.
However, it is not clear what is the best method to detect the in vivo corrosion extent. It was reported from in vitro experiments that Cr alloys, in which the Cr content was at less than 11%, were easily corrosive. 7) Moreover, it was suggested that in vivo biological circumstances such as low O 2 pressure, and the localized acidic condition by macrophages may accelerate corrosion.
However, there has been no systematic study of the relationships among metal corrosion, organ accumulation and urinary excretion of Cr and Fe ions from metal alloys containing various amounts of Cr and Fe.
Binary alloys of Cr-Fe are no longer used in dental and orthopaedic applications, and were used only for comparative purposes in the present study.
Thus, we evaluated the in vivo stability of Fe-Cr alloys mostly by monitoring urinary excretion of the constituent metals (Cr and Fe) non-invasively and continuously, and by determining their concentrations in various organs and blood at the final period of the study.
Materials and Methods

Reagent chemicals for analysis
Stock solutions of 1000 ppm Cr and Fe in 1 N nitric acid were of atomic absorption analysis grade (Wako Pure Chemical Industries, Ltd., Osaka). Distilled water was deionized with Milli-Q (Nihon Millipore Kogyo K.K., Yonezawa). Nitric acid and HClO 4 were of metal analysis grade (Wako Pure chemical Industries, Ltd., Osaka).
Materials
Fe-Cr alloys were prepared from high purity materials, such as electrolytic Fe (> 99.9%) and electrolytic Cr (> 99.9%) using an argon arc melting furnace containing a water-cooled copper hearth and a non-consumable tungsten electrode.
The metal materials were melted and solidified into but- Fig. 1 Body weight changes in rats during 4-months implantation. Fig. 2 Comparison of relative organ to body weights ratios after the 4-month-implantation. The relative organ to body weights ratios in the implant-group were calculated when the average of controls was expressed as 100%. ton shapes in a cavity on the copper hearth. The ingots were then turned over and re-melted at least five times to insure alloy homogeneity. The ingots were cold-rolled to approximately 30% thickness reduction at room temperature followed by annealing at 1000
• C for 30 minutes to eliminate residual stresses and quenching to avoid precipitation of the sigma phase. This process was repeated three times to obtain plates with 1.0 mm thickness after final rolling. The plates were cut into small pieces of with dimensions of 10 mm × 20 mm × 1.5 mm using an abrasive diamond wheel cutter.
Each piece was polish with 600 grid emery paper followed by alumina buff polishing to obtain specimens with a mirrorlike finished surface and 1 mm thickness. In the case of 100% Cr specimens, no cold-rolling was conducted. Specimens with a 10 mm × 20 mm × 1.5 mm size were cut from the button shape ingots using the diamond wheel cutter and then polished by the methods stated above.
The following six kinds of metal implants (10 mm×20 mm, thickness, 1 mm) were prepared: 10%Cr-90%Fe (10%Cr alloy), 15%Cr-85%Fe alloy (15%Cr alloy), 20%Cr-80%Fe alloy (20%Cr alloy), 30%Cr-70%Fe alloy (30%Cr alloy), 
Animal experiments
Five week-old F344 female rats were used and were supplied from Japanese Charles River Co. Twenty-eight rats were randomly assigned to seven groups of four rats for implantation of SUS, 10%Cr, 15%Cr, 20%Cr, 30%Cr alloy, 100%Cr and sham-operation (control group). One sample (piece) was implanted in each rat, in a subcutaneous pocket at the right side of the back one. All animal groups were sacrificed four months after implantation.
All animals used in the investigations were cared for according to the Animal Rights Act and the NIHS-Japan guidelines for Care and Use of Laboratory Animals.
Determination of chromium and iron
A portion of liver (about 0.3 g), kindly (About 0.3 g), and blood (0.5 ml) were digested with mixed acid of nitric acid and Perchloric acid. After digestion, the solutions were diluted with distilled water. The Cr and Fe concentrations were determined using an inductively coupled plasma (ICP)-emission spectrometer Model ICAP-61 (Thermo-Jarrell Ash Co., Ltd.).
Urinary samples were collected into clean glass vessel us- tistical differences shown in Table 1 . In the liver, the 10%Cr group showed higher amounts than the other groups. In the kidney, the 15%Cr group also showed higher amounts than the other groups. However, there was no significant difference among the four groups ranging from 10% to 20%Cr, with a tendency to increase the Cr concentration in any organ in comparison with controls because of its large standard deviations (Fig. 5) . Figure 6 shows Fe amounts detected in the blood, liver and kidney. A slight increase in Fe concentration was found in the blood of the 18%Cr (SUS) group and in the kidney of the 20%Cr group, although there was no significant difference. Figure 7 shows the microphotograph of retrieved implants although we did not identify the implanted animal number indicated in Figs. 3 and 4 . Implants of 10% and 15%Cr al-
Microscopic observation of the metal implants
The retrieved samples were observed microscopically using a stereomicroscope (Olympus, SZH), and further sputtercoated with gold (15.0 nm thick) and viewed using a Hitachi model S-450 scanning electron microscope.
Results and Discussion
The body weights of the animals were measured at intervals up to 4 months afterthe implantation (Fig. 1) . The periods of 4 months were considered to be enough to induce the immuno-histological reaction with biomaterials. The immuno-histological studies will be reported in the separate paper. 8) There were no significant differences of body weights among all experimental groups. Figure 2 shows the normalized relative organ weights (%) which were obtained by dividing the organ weight with body weight follow by normalization using the quotient of the control group.
The values of the left kidney in the SUS group were slightly decreased in comparison with controls (P < 0.05). In the other organs such as liver, spleen, thymus and right kidney, no significant differences in comparison with the controls were found (Fig. 2) . Figure 3 shows the daily amounts of Cr excretion in urine. Each group line in the figure shows the time course of Cr excretion from each animal. Open markers (circle, triangle and square) are those from the treated animals, and closed ones are from the control animals. It is apparent at a glance that larger amounts of Cr was excreted from the treated animals than from the control animals when 15%Cr alloy was implanted. A similar tendency might be observable in the case of 20%Cr alloy implantation. However, it was difficult to identify such differences between the treated and control groups for other alloys. However, the differences were significant for the SUS and the 30%Cr groups by statistical analysis (Table 1) . Table 1 shows that a significant increase in Cr excretion in urine was observed in the animals implanted with the alloys containing Cr of 15-30%, and that the difference was largest in the case of 15%Cr alloys. Similar but somewhat different tendencies were found in the Fe excretion (Fig. 4) . The largest difference was also in the 15%Cr group followed by the 10%Cr group. However, no significant difference was found in the other groups (Table 1) . Figure 5 shows the Cr concentrations in the blood and organs at 4 months after implantation. Cr levels in the blood tended to increase in the 18%Cr and 20%Cr groups. This tendency approximately coincided with the extent of the staing the animal metabolic cages which were previously siliconized to protect the metal releasing from the cages, and excreted urines during 24-hous were collected at each measuring date. Thus, Day 1-urinary measuring values were obtained from those of the urine excreted from 0 to 24 h after implantation. Analysis of Cr and Fe concentrations was carried out similarly described previously in this paper.
Statistical analysis of urinary samples was carried out by the related 2-Group' Wilcoxon Test, and that for organs and blood samples was by Student's t test.
loys may be corroded with the Fe rust. Other implants did not show such brownish colored rust as observed in the 10% and 15%Cr implants. However, one implant of 100%Cr was broken, because of its weak mechanical strength.
When the implant surfaces were observed at higher magnification, severely corroded surfaces were observed in the 15%Cr group, and a corroded hole was observed even in the 30%Cr implant (Fig. 8) .
Generally, corrosion behavior is complex and involves several parameters, e.g. composition and treatment of the alloys, and pH and oxygen concentration in the medium variations. To simulate corrosion during subcutaneous implantation under conditions of no active loading, the release of metals from alloys has been demonstrated from microscopical observations ( Figs. 7 and 8 ). Black and Woodman 9) reported that corrosion products of stainless steel were protein complexes of Cr and Ni organometallic compounds formed at the metal/tissue interface.
A large number of products of Cr and Ni based alloys are commercially available at present. Corrosion properties of such alloys have been extensively studied by electrochemical methods, e.g. by various forms of potentiodynamic techniques. However, information about the release kinetics of specific elements either naturally or in body fluids from such alloys appears limited. 10) The corrosion resistance of Fe increases with increasing Cr content of the alloy. According to Esperik, 10) the release of Ni and Cr from base metal alloys containing more than about 27%Cr could not be detected, while significant amounts of Ni and Cr release could be observed when the Cr content of the alloy was below about 16% in their in vitro studies. 9) However, in the present in vivo studies, Cr was excreted at significant amounts into urine even when 30%Cr alloys were implanted (Table 1) . Therefore, there is a possibility that implanted alloys may be corroded more severely in vivo than in vitro, 11) although the each alloy system such as Ni-Cr vs. Fe-Cr was expected to behave differently.
From this study model of Fr-Cr alloy, it is suggested: firstly, Cr and Fe amounts excreted in urine are useful indices to evaluate the extent of the in vivo corrosion of Cr-Fe alloys. Secondly, the evaluation of the surface of retrieved implants by the naked eye did not correlate with the extents of the Cr or Fe excretion in the body fluid. Thirdly, Cr and Fe accumulations in organs such as liver and kidney were not so significant during the implantation period up to 4 months.
